| Title | Author(s) | Year | View Count |
 | Regulation of p21, MMP-1, and MDR-1 expression in human colon carcinoma HT29 cells by Tian Xian liquid, a Chinese medicinal formula, in vitro and in vivo | Sze, SCW; Wong, KL; Liu, WK; Ng, TB; Wong, JH; Cheung, HP; Yow, CML; Chu, ESM; Liu, Q; Hu, YM; Tsang, KW; Lee, WS; Tong, Y | 2011 | 129 |
 | Effects of Erxian decoction, a Chinese medicinal formulation, on serum lipid profile in a rat model of menopause | Sze, SCW; Cheung, HP; Ng, TB; Zhang, ZJ; Wong, KL; Wong, HK; Hu, YM; Yow, CMN; Tong, Y | 2011 | 74 |
| Quality assessment of Cortex phellodendri by high-performance liquid chromatography coupled with electrospray ionization mass spectrometry | Hu, YM; Su, GH; Sze, SCW; Ye, W; Tong, Y | 2010 | 151 |
| Identification of the major chemical constituents and their metabolites in rat plasma and various organs after oral administration of effective Erxian Decoction (EXD) fraction by liquid chromatography-mass spectrometry | Hu, YM; Wang, YT; Sze, SCW; Tsang, KW; Wong, HK; Liu, Q; Zhong, LD; Tong, Y | 2010 | 267 |
| Simultaneous Analysis of Lipid-Soluble Constituents of Erxian Decoction by GC-MS | Hu, YM; Sze, SCW; Zhang, XQ; Tong, Y | 2009 | 34 |
 | Identification of the multiple chemical constituents from a Chinese medicinal prescription- Erxian Decoction by LC-DAD-ESI-MS | Hu, YM; Wu, JJ; Liu, Q; Sze, CW; Zhong, L; Tong, Y | 2009 | 171 |
| Use of LC fingerprinting to evaluate the quality of Erxian decoction | Hu, YM; Sze, SCW; Zhao, SX; Tong, Y | 2009 | 30 |
|
